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ABSTRACT
Although distal regulatory regions are frequent
throughout the genome, the molecular mechanisms
by which they act in a promoter-specific manner
remain to be elucidated. The human b-globin locus
constitutes an extremely well-established multi-
genic model to investigate this issue. In erythroid
cells, the b-globin locus control region (LCR)
exerts distal regulatory function by influencing
local chromatin organization and inducing high-
level expression of individual b-like globin genes.
Moreover, in transgenic mice expressing the entire
human b-globin locus, deletion of LCR-hypersensi-
tive site 2 (HS2) can alter b-like globin gene expres-
sion. Here, we show that abnormal expression of
human b-like globin genes in the absence of HS2 is
associated with decreased efficacy of pre-initiation
complex formation at the human e- and c-promo-
ters, but not at the b-promoter. This promoter-
specific phenomenon is associated with reduced
long-range interactions between the HS2-deleted
LCR and human c-promoters. We also find that
HS2 is dispensable for high-level human b-gene
transcription, whereas deletion of this hypersensi-
tive site can alter locus chromatin organization;
therefore the functions exerted by HS2 in trans-
criptional enhancement and locus chromatin
organization are distinct. Overall, our data delineate
one mechanism whereby a distal regulatory
region provides promoter-specific transcriptional
enhancement.
INTRODUCTION
The precise regulation of multiple genes through the inter-
mediacy of both proximal and distal cis-regulatory regions
is prerequisite for normal development and cellular diﬀer-
entiation. Speciﬁc transcription factors (TFs) initially bind
these regions and favor the recruitment of yet other TFs
and co-factors. The combinatorial eﬀect of these factors
then modulates chromatin remodeling, covalent modiﬁca-
tion of histones and/or long-range chromatin interactions
that facilitate either gene-activation or -repression (1–6).
The human b- (hub-) globin locus provides a powerful
model to investigate the roles of cis-regulatory regions
and TFs. This locus is comprised of ﬁve developmentally
regulated genes: embryonic e-, fetal
Gg- and
Ag- as well as
adult d- and b-globin genes. Mutations aﬀecting either
expression of the hub-globin gene, or composition of
b-globin chains, can result in b-thalassemia or sickle-cell
anemia. Treatments for these diseases aim primarily at the
transcriptional reactivation of fetal globin genes in adult
bone marrow, but are not always eﬃcient (7). As such, the
development of new molecular therapeutic strategies to
stimulate hub-globin locus transcription is considered an
important challenge for the future.
Transgenic mice carrying the complete hub-globin
locus express the e- and g-genes in primitive erythroid
cells (EryCs) derived from yolk sac. Around embryonic
day 11 (e11), fetal liver EryC primarily express hug-
genes. Soon after, during g-to-b-globin switching, g-gene
transcription progressively decreases which is concomitant
with b-gene transcriptional activation (8). In general, spe-
ciﬁc TFs and co-factors recruited to the b-globin locus
inﬂuence locus chromatin organization and/or promote
long-range chromatin interactions and, as such, are
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b-like globin genes (9–13). For example, GATA-1 and
erythroid Kru ¨ ppel-like factor (EKLF) recruit the histone
acetyltransferase CREB-binding protein (CBP), the his-
tone deacetylase HDAC1 (14–18) and various chromatin
remodeling complexes to the locus (18–20). EKLF is
required for the recruitment of E-RC1 (erythroid-
remodeling complex 1) to adult b-like globin gene promo-
ters (21). The p45 subunit of NF-E2 (p45), another TF
important for regulation of the hub-globin locus, can
also bind CBP (22), HDAC1, and the chromatin remodel-
ing factor BRG1 (23). Finally, in addition to their roles in
facilitating histone covalent modiﬁcation, GATA-1 and
p45 were shown to interact with speciﬁc pre-initiation
complex (PIC) subunits (24,25).
The erythroid-speciﬁc b-globin LCR, composed of ﬁve
DNaseI hypersensitive sites (HS) located 50 of the locus,
induces high-level globin gene expression by mediating
long-range chromatin interactions that maintain close
proximity between the LCR and active globin gene pro-
moters (26–29). In humans (30) and transgenic mice
(31,32), due to position eﬀects, truncated LCRs are not
able to prevent abnormal gene expression as eﬃciently as
complete ones. For instance, in EryC derived from trans-
genic mice lacking HS2, hub-like globin genes are abnor-
mally regulated when the transgene is integrated within
pericentromeric regions (31). In murine fetal and adult
EryC, the abnormal pattern of hub-gene expression is
caused by position eﬀect variegation (PEV) (31,33), char-
acterized by stochastic repression of transcription in a
subset of cells due to the spreading of heterochromatin
from genomic sites adjacent to the transgene (34).
The LCR has been proposed to act as a holocomplex
(35,36). Deletion of any among the ﬁve HS regions can
destabilize this holocomplex, thereby preventing long-
range chromatin interactions critical for high-level globin
gene transcription (37,38). However, molecular dissection
of the LCR strongly suggests that each HS exerts distinct
functions. For instance, HS2 alone can enhance globin
gene expression in EryC, although it does not protect
transgenes from position eﬀects (39). It has also been
reported that globin gene expression can be inﬂuenced
diﬀerentially depending upon the precise HS region
deleted (31,36,37,40–43). Indeed, transgenic mice carrying
an HS2 deletion were characterized by decreased hug- and
hub-globin gene expression in yolk sac-, fetal liver- as well
as bone marrow-derived EryC (36), although dissenting
studies revealed no signiﬁcant eﬀect on expression of
these genes in early fetal liver EryC (37). Finally, when
the endogenous murine HS2 is deleted, embryonic genes
are barely aﬀected while the expression of adult genes is
decreased by up to 30% (42,44). Therefore, the inﬂuence
of HS2 over globin gene expression might be variable
during ontogeny, and the role of HS2 in mediating tran-
scriptional enhancement remains to be further clariﬁed.
It has been proposed that HS2 is involved in PIC
nucleation, since TATA-binding protein (TBP) and the
general transcription factor IIB (TFIIB) are recruited to
HS2 in both bone marrow hematopoietic progenitor cells
and EryC (33,45). In addition, Johnson et al. (46) sug-
gested that in EryC, phosphorylated RNA polymerase II
(Pol II) is recruited to HS2 and then transferred to globin
gene promoters. These data suggest that the LCR, and
more speciﬁcally HS2, might enhance transcription by
facilitating recruitment of PIC constituents that, in turn,
contribute to PIC formation and stability at globin gene
promoters. Moreover, HS2 was shown to be important
for the recruitment of histone modifying complexes and
chromatin remodeling activities (47,48), suggesting that in
addition to its enhancer activity this hypersensitive site
may be involved in locus chromatin organization.
However, it is not clear if HS2 promotes PIC formation
and chromatin reorganization activities at the same time,
or if these events are coordinated separately during
development.
Here, we have characterized the molecular mechanisms
by which HS2 aﬀects globin locus chromatin organization
and globin gene expression in EryC isolated from yolk
sac at e10.5 and from fetal liver at e12.5. Speciﬁcally, we
investigated (i) recruitment of TFs, chromatin-modifying
factors and PIC components, in addition to (ii) long-range
chromatin interactions in transgenic mice containing
the entire human b-globin locus deleted or not for the
HS2 region. Our results demonstrate that HS2-enhancer
activity can be exerted in a promoter-speciﬁc manner,
and that the capacities of HS2 to induce transcriptional
enhancement and locus chromatin organization are
distinct.
MATERIALS AND METHODS
Transgenic mouse lines
Ln2 homozygous embryos (transgene copy number: 2) (8)
were collected at e10.5 or e12.5. E10.5 embryos were
washed twice in phosphate-buﬀered saline (PBS) and
yolk sacs disrupted and punctured in order to collect
blood cells; e12.5 fetal livers were isolated and homoge-
nized in PBS. 2B homozygous mice (31) were crossed
with CD1 females and EryC from heterozygous 2B
(transgene copy number: 3) e10.5 yolk sacs or e12.5 fetal
livers were isolated as described above. Finally, 2C
homozygous mice (31) were bred together and homozy-
gous 2C
+/+ (transgene copy number: 2) e10.5 yolk sacs
or e12.5 fetal livers were isolated. All animal experiments
were conducted in strict accordance with Canadian
Council on Animal Care (CCAC) guidelines, and
approved by the Maisonneuve-Rosemont Hospital
animal care committee.
Chromatin immunoprecipitation (ChIP) and quantitative
real-time PCR (qPCR) assays
ChIP assays were carried out as per manufacturer’s
instruction (Millipore). Brieﬂy, cells were cross-linked
in 1% formaldehyde for 10min at 378C. Cells were then
incubated in lysis buﬀer containing 1mg/ml aprotinin
and 1mM phenylmethanesulphonylﬂuoride (PMSF) and
sonicated in order to obtain chromatin fragments of
400bp on average. After centrifugation for 10min at 13
000 r.p.m., chromatin was diluted 1:10 in the presence of
protease inhibitors and pre-cleared for 30min with salmon
sperm DNA/Protein A agarose beads (Millipore).
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antibodies overnight at 48C. Beads were then washed with
low-salt buﬀer, high-salt buﬀer, LiCl buﬀer and twice
with TE buﬀer (Millipore). Chromatin fragments were
eluted from beads in elution buﬀer (0.1M NaHCO3,1 %
SDS). De-cross-linking was carried out for 4h at 658C.
Following proteinase K treatment, DNA was phenol–
chloroform extracted, precipitated with ethanol and
resuspended in water. Antibodies used were against
tetra-acetylated histone H4 (K3, K8, K12 and K16),
di-acetylated histone H3 (K9 and K14), di-methylated his-
tone H3 (K4) and HDAC1 (Millipore); TBP (SI-1), TFIIB
(C-18), p45 (C-19), GATA-1 (N6), Pol II (N-20), CBP
(A-22) and BRG1 (H-88) (Santa Cruz); unmodiﬁed his-
tone H1 (B419 AE-4) and di-methylated histone H3 (K9)
(Abcam); and polyclonal anti-EKLF (kindly provided by
S. Philipsen) (49). All antibodies were raised in rabbit
except H1 and GATA-1 which, respectively, were raised
in mouse and in rat. Isotype matched immunoglobin
G (IgG) (SantaCruz) were used as control. About 1/30th
of immunoprecipitated and unbound (input) material was
used as template for duplex semiquantitative hot PCR
(AcH3, AcH4, meK4 and TBP ChIP) or qPCR (meK9,
H1, TFIIB, Pol II, EKLF, GATA-1, p45, BRG1, CBP,
HDAC1 and IgG ChIP) with one primer set speciﬁc for
human b-globin regions (HS3, HS2, hue-, hug- and hub-
globin gene promoters and coding regions) and another
primer set speciﬁc for the internal control. For duplex
quantitative PCR, reactions were performed in parallel
under conditions of linear ampliﬁcation and products
were quantiﬁed by PhosporImager; Zfp37 (neural-speciﬁc
Zinc-ﬁnger protein 37) was used as internal control (3,50);
Thp (Kidney-speciﬁc Tamm-Horsfall protein) (51) as neg-
ative control; and mouse HS2 (mHS2; e10.5 EryC) or
 major (bmaj; e12.5 EryC), as positive controls. For
qPCR, reactions were performed using SYBR Green
(Invitrogen) with the iCycler iQ
TM (BioRad) system; Thp
was used as internal control, amylase 2.1y [amy, (30)] as
negative control and mHS2 or bmaj as positive controls.
Since Zfp37, Thp and amy are repressed in EryC, for H1,
meK9 and HDAC1 ChIP, Thp was used as positive con-
trol relative to Gapdh (active in EryC) and mHS2 or bmaj
were used as negative controls. Quantiﬁcation was carried
out according to the 2
–Ct method. Primer sequences are
available on request.
Quantitative RT-PCR (RT-qPCR)
Total RNA was isolated by Trizol (Invitrogen) and used
for cDNA synthesis with oligo(dT)12–18 or random pri-
mers and SuperScript Reverse Transcriptase III
(Invitrogen). qPCR was carried out with QuantiTect
probes speciﬁc for hub-o rh u g-globin cDNA (33).
Intronic or LCR regions and mouse actin or GAPDH
transcripts were detected by SYBR Green (Invitrogen).
The following equation (52) was employed for quantiﬁca-
tion and the ratio corrected for transgene copy number:
ratio ¼
Etarget
 CPtargetðcontrol sampleÞ
Eref ðÞ
CPrefðcontrol sampleÞ
Etarget: target qPCR eﬃciency; Eref: control qPCR eﬃ-
ciency; CP: crossing point; CPtarget: CP deviation of
ln2 versus 2B lines target gene transcript; CPref:C P
deviation of ln2 versus 2B lines mouse control tran-
script. Primer sequences are available on request.
RNA–Fluorescent in situ hybridization (FISH)
RNA–FISH was performed as described in Wijgerde et al.
(53) and van de Corput et al. (54). A detailed procedure
is available as Supplementary Data (Figure S1).
DNaseI sensitivity assay
DNaseI sensitivity assay was carried out as previously
described (50). About 300000 nuclei were digested with
up to 0.3U of DNaseI (Roche, Indianapolis) for 30min
on ice and puriﬁed DNA was used as template for qPCR.
Average molecular weight of DNaseI-treated samples was
determined by Southern blotting.
Chromosome conformation capture (3C)
Chromosome conformation capture was carried out as
described in Dekker et al. (55) and Bottardi et al. (56).
A detailed procedure is available as Supplementary Data
(Figure S1).
Hemoglobin staining
Intracellular staining was carried out on e12.5 fetal liver
cells isolated from either ln2 or 2B mice. Ten to twenty
million cells were ﬁxed in 2% formaldehyde for 15min at
room temperature, and washed once with PBS and once
with PBS/5% heat-inactivated fetal bovine serum (FBS)
(PBS/FBS). For ChIP and DNaseI assays, cells were then
permeabilized with 1ml of PBS/FBS/0.5% saponin for
10min at room temperature and stained with 20mgo f
ﬂuorescein isothiocyanate (FITC)-conjugated anti-HbA
antibodies (clone 37-8, Santa Cruz) for 30min at room
temperature. Cells were washed in PBS/FBS/0.5% sapo-
nin and then again in PBS/FBS, and sorted by high-speed
ﬂuorescence-activated cell sorting (FACS) (FACS
Vantage with DIVA option; Becton Dickinson, San
Jose, CA, USA). To select for 2B EyC, which do not
express the human hemoglobin b-chain (HbA
  cells),
anti-HbA antibodies were coupled to rat anti-mouse
Ter119 antibodies, followed by allophycocyanin (APC)-
conjugated goat anti-rat IgG (Leinco Technologies) stain-
ing to isolate Ter119
+HbA
  cells. Indeed, Ter119 anti-
body recognizes maturing erythroid cells from the
proerythroblast stage onward (57). For variegation
study, 1 million e12.5 fetal liver cells were permeabilized
in 90% methanol for 10min on ice. Cells were then stained
with 1mg of either FITC-conjugated anti-HbA antibody
(as above) or FITC-conjugated anti-HbF antibody
(clone 51-7, Santa Cruz). Cells were washed once in
PBS/FBS and analyzed by FACScan (Becton Dickinson
Immunocytometry System (BDIS), San Jose, CA, USA).
These anti-HbA and anti-HbF do not cross-react with the
murine globin chains (data not shown).
Nucleic Acids Research, 2009,Vol.37, No. 16 5297Figure 1. HS2 deletion aﬀects PIC formation at hug-promoters and long-range interactions among LCR and hug-globin genes in e10.5 EryC.
(A) Schematic representation of the human b-globin locus. Regions (amplicons) analyzed by ChIP are represented by horizontal lines. Due to high
sequence similarity at hug-promoters and at hug-genes, the same primer sets amplify both the hu
Ag- and hu
Gg-promoters or genes; (B) RNA puriﬁed
from ln2 and 2B e10.5 yolk sacs (e10.5) was retro-transcribed. Transcript quantiﬁcation was made by qPCR, and relative levels of transcription
(Ln2/2B) were calculated according to Pfaﬄ (52) using mouse actin cDNA as internal control; HS4 or HS3 transcript: HS4 or HS3 primary
transcript; HS3-HS2 transcript: primary transcript of the intergenic region between HS3 and HS2; hue mRNA: hue-globin mRNA transcript; hue
intron 1 or 2 transcript: e-globin intron 1 or 2 primary transcript; hug mRNA: hug-globin mRNA transcript; hug intron 1 or 2 transcript: g-globin
intron 1 or 2 primary transcript (both
Ag and
Gg transcripts are ampliﬁed with the primer sets used); (C) Representative example of RNA–FISH on
ln2 and 2B e10.5 yolk sacs (e10.5). Green signals: mouse a-globin primary transcript (moa; FITC detection); red signals: hug-globin primary
transcript (hug; Texas Red detection; both
Ag and
Gg are recognized by the probes); (D–H) ChIP assays were carried out on e10.5 yolk sacs (e10.5;
gray bars: ln2; white bars: 2B; dashed bars: 2C). Immunoprecipitated and input chromatin samples from TBP ChIP were subjected to duplex
semiquantitative hot PCR and from TFIIB, Pol II and RabIgG (rabbit IgG) ChIP to qPCR. Fold enrichment (y-axis) of globin regions relative to
the control and input samples are represented by bars, with corresponding standard deviations. A value of 1 (dashed line) indicates no enrichment.
The positive control for TBP, TFIIB and Pol II ChIP is represented by m (mouse b-globin HS2; mHS2/Thp) and the negative control by a
(amy/Thp); hash sign (#): P 0.05 according to Student’s t-test (ln2 versus 2B or ln2 versus 2C). The regions analyzed are speciﬁed on each
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Globin gene expression in ln2 and "2B yolk sac EryC
To deﬁne the role of HS2 on globin gene expression
during ontogeny, we investigated the eﬀect of HS2 dele-
tion on hue- and hug-gene expression in e10.5 yolk sac
and e12.5 fetal liver EryC derived from ln2 and 2B mice.
Ln2 transgenic mice carry the 70-kb hub-globin locus
(Figure 1A), and express high-levels of hub-like globin
genes in a developmentally regulated manner (8). The
2B transgenic mice carries the same construct as ln2
except for a deletion of a 742-bp ApaLI–SnaBI fragment
encompassing HS2, and they express hub-like globin genes
abnormally at all stages of development (31). Accordingly,
quantitative RT-PCR (RT-qPCR) analysis indicates that
in ln2 e10.5 EryC, hue- and hug-globin messenger RNA
(mRNA) levels are, respectively,  10-fold and  4-fold
higher relative to 2B (Figure 1B). The pattern of hug-
gene expression was also investigated at the single-cell
level by RNA–FISH using mouse a-globin transcript as
internal control. We observed that hug-genes are tran-
scribed in all 2B e10.5 EryC because EryC, which can
transcribe the endogenous murine a-globin gene, are also
competent in hug-gene transcription (Figure 1C). This
indicates that in contrast to the PEV expression pattern
that characterizes hub-gene expression in 2B e13.5 fetal
liver and bone-marrow-derived EryC (where only 25% of
EryC express the hub-gene) (31), abnormal hug-gene
expression in 2B e10.5 EryC is not attributable to PEV.
Toward understanding the origin of abnormal hub-like
globin gene expression in e10.5 EryC, we investigated
hue- and hug-primary transcript levels. In addition,
since the LCR has been reported to inﬂuence transcrip-
tional elongation of globin genes (58), we set out to deter-
mine whether the impaired hue- and hug-gene expression
in 2B e10.5 EryC could be related to abnormal transcrip-
tional elongation. We observed that for both genes (i) pri-
mary transcript levels decrease in 2B cells but do not
vary between introns 1 and 2 and (ii) the ratio of primary
gene transcripts versus mRNA is similar in ln2 and 2B
e10.5 EryC (Figure 1B). Taken together, these results indi-
cate that decreased hue- and hug-gene transcription in
2B e10.5 EryC is not a consequence of variegated
expression, but rather is due to the absence of HS2,
which alters expression levels without aﬀecting transcrip-
tional elongation.
PIC formation and long-range chromatin interactions at
the hub-like globin locus in ln2 and "2B yolk sac EryC
To elucidate the mechanism(s) inﬂuencing human
globin gene expression in 2B e10.5 yolk sac EryC, we
ﬁrst studied PIC formation at hue- and hug-promoters.
Recruitment of the PIC subunits (59) TBP, TFIIB and
Pol II was assessed by ChIP assay on ln2 and 2B e10.5
EryC. Since regulation of the mouse b-globin locus is
normal in all transgenic mouse lines utilized, mouse
LCR HS2 was used as positive control, and amylase as
negative control, for ChIP assays (Figure 1H). As shown
in Figure 1D–F, reduced detection of TBP, TFIIB and Pol
II at HS3, hue-, and hug-promoters suggests that PIC
formation or stability is aberrant in the absence of HS2
in 2B e10.5 EryC.
Since it is proposed that long-range chromatin interac-
tions are important for PIC formation/stability at promo-
ters (46), we analyzed the interactions between the
LCR and diﬀerent regions across the b-globin locus
using the chromosomal conformation capture (3C) assay
(55). Nuclei were treated with formaldehyde, and the
cross-linked genomic DNA digested and ligated.
Genomic DNA fragments located in close proximity are
more susceptible to ligation, and the frequency of ligation
events can be detected by qPCR using appropriate primer
sets (Figure 1I). Interestingly, we observed that HS2
deletion speciﬁcally aﬀects long-range chromatin interac-
tions between LCR and hug-genes in 2B e10.5 EryC
(Figure 1I), which is consistent with altered PIC formation
at hug-promoters and low-level hug-gene transcription in
these cells. Possibly due to their linear proximity, no sig-
niﬁcant variation in frequency of contact between LCR
and the hue-region could be detected.
In order to further understand the basis for abnormal
globin gene expression in 2B e10.5 EryC, we investigated
EKLF, GATA-1 and p45 recruitment to the b-globin
locus (Figure 2A–D). As shown in Figure 2C, only p45
recruitment to hug-promoters is signiﬁcantly aﬀected in
2B cells. Among the co-factors interacting with p45
and capable of inﬂuencing locus organization (23), we
noted a reduction and increase, respectively, of BRG1
and HDAC1 recruitment to hue- and hug-promoters
(Figure 2B and C). Thus, in addition to being important
for PIC formation/stability, and for proper long-range
chromatin interactions between the LCR and hug-
promoters in e10.5 EryC, the presence of HS2 appears
to be required to ensure recruitment of p45 and BRG1
to hue- and hug-promoters. In summary, our results indi-
cate that HS2 is ﬁrmly involved in transcriptional
enhancement of hue- and hug-genes in e10.5 EryC.
PIC formation and long-range chromatin interactions at
the hub-globin locus in ln2 and "2B fetal liver EryC
Based on the above results, we investigated whether
altered PIC formation and impaired long-range chromatin
interactions might also take place in 2B e12.5 fetal liver
EryC, where hug- and hub-globin genes (both active at
graph and the antibodies used for ChIP assays are indicated underneath each graph; (I) 3C assay performed on e10.5 yolk sacs (e10.5; gray line: ln2;
dashed line: 2B). 3C ligation products were used as templates for qPCR analysis of the regions indicated on the x-axis. EcoRI digestion sites are
shown by vertical arrows on the locus and fragments of interest are delimited by gray boxes. A primer set is formed by the combination of HS4-HS2
primer (ﬁxed point) and one of the following primers: e:h u e-gene; ie-g: intergenic region between hue- and hug-gene; g:h u
Gg- and hu
Ag-genes;
Ag:
hu
Ag-gene; cb: cb gene; ig-d: intergenic region between hu
Ag- and hud-gene; d:h u d-gene; id-b: intergenic region between hud- and hub-gene; b:h u b-
gene. Relative cross-linking frequency (y-axis) of the ﬁxed point with globin fragments was deﬁned using naked DNA as control and normalized
to mouse actin. A relative frequency of one was attributed to the highest cross-linking frequency; asterisk (
 ): P 0.001 according to Student’s t-test
(ln2 versus 2B); e12.5 brain cells (dotted line), in which human b-like globin genes are not expressed were used as control.
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pattern of expression (31). We observed that TBP recruit-
ment to HS3, hug- and hub-promoters is not signiﬁcantly
aﬀected in 2B e12.5 EryC, whereas TFIIB recruitment
and Pol II loading are clearly less eﬃcient in 2B than in
ln2 cells (Figure 3C–E). TBP binding was conﬁrmed in
another PEV line, namely 2C (31), in which the
same globin locus as 2B is integrated in a restrictive
chromosomal environment that allows expression of the
hub-globin gene in only 4% of 2C EryC (Figure 3C–E
and Figure S3C). Recruitment of TBP to a TATA box
embedded in restrictive chromatin has been previously
documented (60). However, due to reduced TFIIB and
Pol II recruitment to globin gene promoters, we believe
that TBP binding is not suﬃcient to promote PIC forma-
tion in 2B e12.5 EryC.
As shown in Figure 3G, the 3C analysis reveals that
even though the LCR is frequently located in close prox-
imity to hug- and hub-promoter regions in 2B e12.5
EryC, such interactions are signiﬁcantly reduced com-
pared to ln2 cells. Since it has been reported that TFs
are important for PIC formation and long-range chroma-
tin interactions, we investigated whether any TFs involved
in chromatin organization and/or long-range interactions
could be abnormally recruited to the b-globin locus. We
observed that EKLF and GATA-1 recruitment to hug-
and hub-promoters is reduced in 2B e12.5 EryC com-
pared with the situation for ln2 cells (Figure 4B and C).
This correlates with the PEV pattern of hug- and hub-gene
expression in 2B e12.5 EryC (Figure 3A and B). p45 can
assist GATA-1 during globin gene activation (24), and it is
therefore interesting that p45 recruitment is also reduced
at both hug- and hub-promoters (Figure 4B and C). We
also observed reduced CBP and increased HDAC1
recruitment, especially at HS3 and the hub-promoter
(Figure 4A and C). However, since EKLF, GATA-1,
and p45 are equally recruited to HS3 in e12.5 EryC
derived from both lines, it is likely that CBP and
HDAC1 recruitment to HS3 is facilitated by TFs other
than those immediately aforementioned, and that the
binding of these yet-to-be identiﬁed TFs at HS3 is reduced
in 2B e12.5 fetal liver EryC. In summary, in 2B fetal
liver EryC, the PEV expression pattern is primarily asso-
ciated with pronounced alteration of TFIIB, Pol II, as well
as EKLF, GATA-1 and p45 binding to hug- and hub-
promoters.
Chromatin organization at the hub-globin locus in
yolk sac and fetal liver EryC
The results presented so far indicate that in 2B e10.5
EryC, reduced hue- and hug-globin gene expression is
not the consequence of PEV; however, later during devel-
opment hug- and hub-gene expression is subject to PEV in
2B EryC [see above and (31,33)]. As such, it was inter-
esting to investigate whether or not chromatin organiza-
tion at the 2B locus varies in e10.5 versus e12.5 EryC.
We therefore carried out ChIP assays using antibodies
directed against di-acetylated histone H3 (AcH3), tetra-
acetylated histone H4 (AcH4) or di-methylated histone
H3 (meK4), all of which are normally associated with
transcriptionally prone chromatin (61). The active mouse
LCR HS2 (m),  major promoter (bmaj) or the inactive
Thp gene (T) or amylase promoter (a) were used as con-
trols (Figures 5F and 6E).
Figure 2. Transcription factor and co-factor recruitment at the hub-
globin locus in ln2 and 2B e10.5 EryC. (A–E) ChIP assays were carried
out on e10.5 yolk sacs (e10.5; gray bars: ln2; white bars: 2B); immuno-
precipitated and input chromatin samples were subject to qPCR. Fold
enrichments were calculated as described in Figure 1 and are indicated
on the y-axis; the positive control for EKLF, GATA-1, p45, BRG1 and
CBP ChIP is represented by m (mHS2/Thp) and for HDAC1 ChIP, by a
(amy/Gapdh). The negative control for EKLF, GATA-1, p45, BRG1 and
CBP ChIP is represented by a (amy/Thp) and for HDAC1 ChIP, by m
(mHS2/Thp). Hash sign (#): P 0.05 according to Student’s t-test
(ln2 versus 2B). The regions analyzed are speciﬁed on each graph and
the antibodies used for ChIP assays are indicated underneath each graph.
5300 Nucleic Acids Research, 2009, Vol. 37,No. 16Figure 3. HS2 deletion aﬀects PIC formation at hub-like globin gene promoters and long-range chromatin interactions between LCR and hub-like
globin genes in e12.5 EryC. (A) RNA puriﬁed from ln2 and 2B e12.5 fetal liver EryC (e12.5) was retro-transcribed. qPCR was performed and
analyzed as in Figure 1; (B) e12.5 fetal liver EryC were stained with anti-HbF or anti-HbA antibodies, as detailed in ‘Materials and Methods’ section;
(C–F) ChIP assays were carried out on e12.5 fetal liver cells (e12.5; black bars: ln2; dotted bars: 2B; checked bars: 2C). Immunoprecipitated and
input chromatin samples from TBP ChIP were subjected to duplex semiquantitative hot PCR and from TFIIB, Pol II and RabIgG (rabbit IgG) ChIP
to qPCR. Immunoprecipitated and input chromatin samples were subject to qPCR. Fold enrichments were calculated as described in Figure 1 and
are indicated on the y-axis. b (maj) control replaces mHS2 control for analysis in fetal liver EryC. Hash sign (#): P 0.05 according to Student’s
t-test (ln2 versus 2B or ln2 versus 2C). The regions analyzed are speciﬁed on each graph and the antibodies used for ChIP assays are indicated
underneath each graph; (G) 3C assay performed on e12.5 fetal liver cells (e12.5; black line: ln2; dashed line: 2B). 3C ligation products were used as
templates for qPCR analysis of regions indicated on the x-axis. Relative cross-linking frequency (y-axis) of the ﬁxed-point fragment (HS4-HS2) with
hub-globin fragments was deﬁned as in Figure 1. Hash sign (#): P 0.05 according to Student’s t-test (ln2 versus 2B).
Nucleic Acids Research, 2009,Vol.37, No. 16 5301Figure 5A–C show that in ln2 e10.5 yolk sac EryC HS4,
HS3, and the hue- and hug-promoters and genes display,
in general, high-levels of AcH3, AcH4 and meK4.
Surprisingly, histone AcH4, known to be associated with
active chromatin organization independent of gene tran-
scriptional status (62), is very similar in ln2 and 2B loci.
Moreover, AcH3 and meK4 levels at the inactive hub-
promoter and gene, as well as at the cb intergenic
region (Figure 5D and E) are similar in ln2 and 2B
and only local variations are detected at the LCR, and at
the hue- and hug-promoters and genes (Figure 5A–C).
In both lines, histone H3 K9 methylation (meK9)
or linker histone H1, both of which are associated with
transcriptionally restricted chromatin (63,64), are not
detected across the locus (Figure 5A–E). Finally, chroma-
tin accessibility as assessed by DNaseI sensitivity assay is
comparable in ln2 and 2B e10.5 EryC (Figure S2A–E).
In summary, since chromatin organization is very similar
in 2B and ln2 cells and manifests no feature of transcrip-
tionally restricted chromatin, it is unlikely that low-level
hue- and hug-gene expression in 2B e10.5 EryC is
related to PEV. Rather, the variations observed at the
hue- and hug-regions in 2B versus ln2 e10.5 EryC are
best explained by altered transcription levels of hue- and
hug-genes (Figure 1B), rather than by restrictive chroma-
tin organization of the b-globin locus per se.
Chromatin organization was next studied in e12.5
fetal liver EryC. As expected, ChIP assays revealed
that throughout the locus AcH3, AcH4 and meK4 are
signiﬁcantly underrepresented in 2B versus ln2 e12.5
EryC, whereas histone H1 recruitment to HS3 and to
the hub-promoter is 2- to 3-fold higher in 2B compared
with ln2 cells (Figure 6A and D). Notably, the level of
meK9 at the hub-promoter is 3-fold lower in 2B versus
ln2 e12.5 EryC (Figure 6C). This could be explained by the
fact that, although frequently observed in repressive chro-
matin, meK9 has also been associated with bmaj active
transcription (65) and other transcriptionally active
genes (66,67). In accord with our ChIP results, DNaseI
sensitivity assays carried out on e12.5 fetal livers revealed
that across the locus, chromatin is less accessible in 2B
than ln2 EryC (Figure S2F–I). Thus, unlike what is
observed at e10.5, in 2B e12.5 EryC, several regions of
the b-globin locus are characterized by decreased histone
acetylation levels and H1 enrichment, which together
are reminiscent of a restrictive chromatin organization
typical of PEV. Overall, these results support a role
for HS2 in locus chromatin organization in e12.5 fetal
liver EryC.
Characterization of a "2B EryC subpopulation
expressing the hub-globin gene
The results shown thus far provide no information as to
whether reduced gene expression, impaired PIC forma-
tion, and abnormal chromatin organization at hub-like
globin promoters in 2B e12.5 EryC might be a conse-
quence of (i) the absence of chromatin remodeling and/or
histone-modifying activities (due to HS2 deletion), or (ii)
altered HS2-mediated enhancer activity as observed in
2B e10.5 EryC. To address this, we compared various
chromatin-related endpoints in ln2 and 2B e12.5 EryC
subpopulations that actively transcribe the hub-gene.
These cells were isolated using an anti-HbA (adult hemo-
globin) antibody speciﬁc for the human hemoglobin
b-chain (HbA
+). Hub-like globin gene expression (by
RT-qPCR), PIC formation (by Pol II and TFIIB ChIP),
and chromatin organization (by AcH3 and AcH4 ChIP
and DNaseI sensitivity assay) were compared in HbA
+
cells. As shown in Figure 7A, no signiﬁcant variation of
hub-gene expression was detected in ln2 versus 2B
HbA
+ cells. Accordingly, we observed that chromatin
organization (Figure 7B and C; Figure S2J–L) and PIC
formation (Figure 7D and E) at the hub-promoter are
similar in ln2 versus 2B HbA
+ cells, while, as expected,
PIC formation and histone acetylation levels are remark-
ably decreased in 2B Ter119
+ HbA
  cells (i.e., EryC not
Figure 4. Transcription factor and co-factor recruitment at the hub-
globin locus in ln2 and 2B e12.5 EryC. (A–D) ChIP assays were
carried out on e12.5 fetal liver EryC (e12.5; black bars: ln2; dotted
bars: 2B. Immunoprecipitated and input chromatin samples were sub-
ject to qPCR. Fold enrichments were calculated as described in
Figure 1 and are indicated on the y-axis. b (maj) control replaces
mHS2 control for analysis in fetal liver cells. Hash sign (#): P 0.05
according to Student’s t-test (ln2 versus 2B). The regions analyzed are
speciﬁed on each graph and the antibodies used for ChIP assays are
indicated underneath each graph.
5302 Nucleic Acids Research, 2009, Vol. 37,No. 16transcribing the hub-globin gene; Figure 7B–E). The
above strongly suggests that the absence of HS2 enhancer
activity does not aﬀect the eﬃcacy of PIC formation or
chromatin organization at the hub-promoter and, further-
more, that HS2 is not required for hub-gene high-level
transcription in e12.5 EryC. Surprisingly, hug-gene tran-
scription is reduced in 2B HbA
+ cells (Figure 7A).
Consistent with this latter observation, chromatin organi-
zation at hug-genes is impaired in these cells (Figure 7B
and C; Figure S2K) and TFIIB and Pol II are recruited
less eﬃciently at hug-promoters (Figure 7D and E). Thus,
as for e10.5 EryC, HS2 deletion in e12.5 EryC precludes
eﬃcient PIC formation at hug-promoters, but has no sig-
niﬁcant eﬀect at the hub-promoter. Since the transcription
level of the hub-gene is not aﬀected in 2B HbA
+ EryC,
even though hub-gene expression is characterized by PEV
in 2B e12.5 EryC, we conclude that the PEV expression
pattern of the hub-gene is not related to absence of
HS2-mediated enhancer activity. Instead, impaired
recruitment of histone-modifying or chromatin-remodel-
ing activities to the locus due to HS2 deletion likely facil-
itates invasion of the locus by restrictive chromatin
organization originating at the genomic integration site
of the transgene.
DISCUSSION
The comparative analysis of hub-like globin gene expres-
sion in e10.5 and e12.5 EryC undertaken here reveals
that in absence of HS2, the hue- and hug-promoters are
characterized by impaired PIC formation as well as abnor-
mal recruitment/stability of speciﬁc TFs and co-factors.
However, at the same time, we show that HS2 is not
required for hub-gene transcriptional enhancement.
Thus, the contribution of HS2 to PIC formation and pro-
moter organization is required for high-level transcription
of some but not all globin genes. Finally, we demonstrate
that in 2B e12.5 EryC, HS2 deletion does not aﬀect
transcription levels of the hub-gene but does facilitate
the induction of abnormal chromatin organization over
the locus. The above, taken together, indicates that HS2
functions separately in transcriptional enhancement and
locus chromatin organization.
Influence of HS2 deletion on hue- and huc-gene
transcriptional enhancement
Here, we showed that low-level globin gene transcription
in 2B e10.5 EryC is a consequence of impaired LCR
enhancer activity due to HS2 deletion, and not of
Figure 5. Eﬀect of HS2 deletion on hub-globin locus chromatin organization in e10.5 EryC. (A–F) ChIP assays were carried out on e10.5 yolk sacs
(e10.5; gray bars: ln2; white bars: 2B). Immunoprecipitated and input chromatin samples from AcH3, AcH4 and meK4 ChIP were subjected to
duplex quantitative PCR and from meK9, H1, RabIgG and moIgG ChIP were subjected to qPCR. Fold enrichment (y-axis) of globin regions
relative to the control and input samples were calculated as described in Figure 1. The negative control for AcH3, AcH4 and meK4 ChIP is
represented by T (Thp/Zfp) and for H1 and meK9 ChIP, by m (mHS2/Thp). The positive control for AcH3, AcH4 and meK4 ChIP is represented by
m( mHS2/Zfp) and for H1 and meK9 ChIP, by T (Thp/Gapdh); asterisks (
 ): P 0.001 according to Student’s t-test (ln2 versus 2B). The regions
analyzed are speciﬁed on each graph and the antibodies used for ChIP assays are indicated underneath each graph; 4 (HS4), 3 (HS3), P (promoter),
G (gene); AcH3: di-acetylated histone H3; AcH4: tetra-acetylated histone H4; meK4: di-methylated lysine 4 histone H3; H1: Histone H1; meK9:
di-methylated lysine 9 and lysine 27 histone H3.
Nucleic Acids Research, 2009,Vol.37, No. 16 5303disruption of the active locus-wide chromatin organiza-
tion. Indeed, in e10.5 EryC, chromatin at the hub-globin
locus is accessible and devoid of heterochromatin marks.
The fact that human globin genes manifest a PEV expres-
sion pattern in e12.5 2B fetal liver EryC but not in e10.5
yolk sac EryC is most likely related to developmental-
stage-speciﬁc spreading of heterochromatin from the
b-globin transgene integration site within the mouse
genome.
We also showed that in 2B e10.5 EryC, variations
in histone covalent modiﬁcations at hug-promoters are
associated with impaired LCR-hug-promoter interactions.
Such variations might be a consequence of abnormal tran-
scription levels in 2B cells, since AcH3 [speciﬁcally at the
b-globin locus (68)], as well as H3K4 di- and tri-methyla-
tion [at various genetic loci (69)], have been associated
with high-level gene transcription. Alternatively, varia-
tions in histone covalent modiﬁcations might be linked
to reduced recruitment of enzymatic activities by TFs
such as p45 (2), which we showed occurs less eﬃciently
at hug-promoters in 2B compared with ln2 cells. In fact,
the correlation between these latter variations, abnormal
PIC formation, altered LCR/hug-gene long-range chro-
matin interactions, and low-level hue- and hug-gene tran-
scription, might not be fortuitous. For instance, reduced
p45 and BRG1 recruitment to hue- and hug-promoters
could be responsible for low hue- and hug-gene expression
levels in 2B e10.5 EryC since both p45 and BRG1 are
required for eﬃcient Pol II occupancy at globin promoters
(19,24,70,71). Moreover, recently, BRG1 has been shown
to aﬀect long-range interactions at the b-globin locus (13).
It should be noted that low AcH3 levels at hug-regions are
not related to CBP recruitment (Figures 5C and 2C), sug-
gesting that eﬀects on the recruitment/stability of other
acetyltransferases binding the b-globin locus, e.g. p300
and PCAF (14,72) might be implicated.
Distal regulatory regions can enhance transcription by
various means including modulation of both PIC forma-
tion and the eﬃcacy of transcriptional elongation. In 2B
e10.5 EryC, we observed a relatively low frequency of
LCR/hug-gene long-range interactions, decreased recruit-
ment of PIC components to the LCR as well as altered
PIC formation at hue- and hug-promoters. Additionally,
we did not detect signiﬁcant variation in TF recruitment at
HS3, nor in DNaseI sensitivity at HS3, in accord with
what has been reported for the mouse b-globin locus
(73). However, we did observe that primary transcription
of HS4, HS3, and inter-HS3-HS2 regions is relatively
reduced in 2B EryC (Figures 1B and 3A). Likewise,
Pol II and TFIIB loading at HS3 (45) is decreased in
these cells (Figures 1D and 3C). This indicates that HS2
is required for proper LCR primary transcription as well
as for TFIIB and Pol II loading at the LCR. The above
data, taken together, suggest that HS2 inﬂuences other
regions of the LCR and, most likely, acts in synergy
with other LCR hypersensitive sites. As previously pro-
posed (45,74), it is possible that low-level LCR intergenic
transcription inﬂuences the recruitment of other TFs to
HS3 in 2B EryC. This is supported by the abnormal
recruitment of BRG1 to HS3 in 2B e10.5 EryC
(Figure 2A). Additionally, as shown for the human
Figure 6. Eﬀect of HS2 deletion on hub-globin locus chromatin organi-
zation in e12.5 EryC. (A–E) ChIP assays were carried out on e12.5 fetal
liver EryC (e12.5; black bars: ln2; dotted bars: 2B). Immunoprecipitated
and input chromatin samples from AcH3, AcH4 and meK4 ChIP were
subject to duplex quantitative PCR and from meK9, H1, RabIgG and
moIgG ChIP were subjected to qPCR. Fold enrichments were calculated
as described in Figure 1 and are indicated on the y-axis. b (maj) control
replaces mHS2 control for analysis in fetal liver cells. The regions ana-
lyzed are speciﬁed on each graph and the antibodies used for ChIP assays
are indicated underneath each graph; 4 (HS4), 3 (HS3), P (promoter),
G (gene); AcH3: di-acetylated histone H3; AcH4: tetra-acetylated histone
H4; meK4: di-methylated lysine 4 histone H3; H1: Histone H1; meK9:
di-methylated lysine 9 and lysine 27 histone H3. Asterisk (*): P 0.001
according to Student’s t-test (ln2 versus 2B).
5304 Nucleic Acids Research, 2009, Vol. 37,No. 16growth hormone LCR (75), primary transcription of the
b-globin LCR could potentially control its ability to par-
ticipate in long-range chromatin interactions and gene
activation.
Our data demonstrating that trans-acting factors
are recruited less eﬃciently to hub-like globin gene pro-
moters in 2B e10.5 EryC, i.e. where the locus is not in
restrictive chromatin organization, strongly suggests that
the HS2-deleted LCR also aﬀects TF and co-factor
recruitment or stability at promoters. Since GATA-1
and p45 can be recruited to globin gene promoters in
the absence of the LCR (11,76), and are reported to inter-
act with some PIC subunits (24,25), it is likely that the
eﬃcacy of PIC formation (which is aﬀected by HS2 dele-
tion in 2B e10.5 EryC) inﬂuences the stability at least of
p45 at hue- and hug- promoters. Thus, we propose that
the main function of HS2 in transcriptional enhancement
is to promote PIC formation at hue- (77) and hug-promo-
ters. This is consistent with previous observations at the
mouse and human b-globin loci, which suggest that LCR-
bound Pol II can be transferred to globin gene promoters,
and that HS2 is the major LCR site for recruitment of
phosphorylated Pol II (46,71,78).
HS2 affects human b-like globin genes differentially
and is involved in locus chromatin organization
The speciﬁc roles of the various LCR HS regions have
been a matter of debate (31,36,37,41,43,79). In particular,
it is not clear if HS2 promotes PIC formation and chro-
matin organization activities at the same time, or if these
activities are coordinated separately during development.
It was reported that in the context of a minimal construct
where HS2 is linked to the b-globin gene, this hypersensi-
tive region constitutes a poor modulator of chromatin
organization but nonetheless retains signiﬁcant trans-
criptional enhancer activity (39). Indeed, chromatin-
modifying and -remodeling activities are recruited to
HS2 (3,47,48) and inﬂuence chromatin organization
across the b-globin locus (47,48). Additionally, HS2 dele-
tion favors abnormal chromatin organization when the
transgene is integrated within chromosomal regions
marked by heterochromatin (31,32). Thus, a PEV pattern
of expression in 2B e12.5 EryC could be facilitated by
the absence of speciﬁc chromatin-modifying or -remodel-
ing activities normally recruited to HS2 (3,47,48) and/or
by reduced eﬃciency of PIC formation/stability at human
b-like globin gene promoters. However, characterization
of the 2B e12.5 EryC subpopulation expressing the hub-
globin gene (2B HbA
+ EryC) indicates that the absence
Figure 7. HS2 deletion speciﬁcally aﬀects hug-globin gene expression
and chromatin organization in HbA
+ e12.5 EryC. Ln2 and 2B e12.5
fetal liver cells were sorted according to hub-globin expression with an
antibody recognizing the human b-globin chain of adult hemoglobin
(HbA
+). (A) Equal amounts of RNA puriﬁed from 2B and ln2
HbA
+ cells were retro-transcribed. qPCR was performed and analyzed
such as in Figure 1; hug:h u g-globin mRNA; hub:hub-globin mRNA;
(B–F) ChIP assays were carried out on ln2 and 2B HbA
+ e12.5 fetal
liver cells (black bars: ln2; dotted bars: 2B) and on 2B Ter119
+
HbA
  e12.5 fetal liver cells (gray bars). Immunoprecipitated and input
chromatin samples were subject to qPCR. Fold enrichments were cal-
culated as described in Figure 1 and are indicated on the y-axis. Hash
sign (#): P 0.05 according to Student’s t-test (ln2 HbA
+ versus 2B
HbA
+ or ln2 HbA
+ versus 2B Ter119
+ HbA
 ). The regions ana-
lyzed are speciﬁed on each graph and the antibodies used for ChIP
assays are indicated underneath each graph.
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the hub-promoter. Since the hub-gene has a characteristic
PEV expression pattern in 2B e12.5 fetal liver EryC,
but is nonetheless equally transcribed in ln2 and 2B
HbA
+ EryC, it appears that alteration of HS2 enhancer
activity is not required for PEV. This also argues in favor
of the notion that HS2 enhancer- and chromatin-activa-
tion functions exhibit dichotomy with respect to one
another (80,81).
HS3 is known to be important for Pol II recruitment to
the hub-promoter as well as for long-range chromatin
interactions in adult EryC (38,41). Here, we show that
PIC components are normally recruited to HS3 in 2B
HbA
+ EryC but not in 2B e10.5 EryC. Based on this,
and supported by a previous literature report (41), we
propose that HS3, in the absence of HS2, is suﬃcient to
enhance hub-gene transcription, although it is unable to
favor proper PIC formation at hug-promoters.
Finally, we observed that chromatin organization at the
b-globin locus is very similar in ln2 and 2B HbA
+ EryC,
suggesting that chromatin in both cell types is favorable
for gene expression. However, chromatin alterations were
detected at the hug-region in 2B HbA
+ EryC (Figure 7B
and C). Since such alterations correlate with abnormal
PIC formation at hug-promoters (Figure 7D and E), we
propose that chromatin organization at globin gene
regions (74) is deﬁned by LCR-facilitated recruitment/
stability of trans-acting factors in direct contact with
these regions, as well as by locus wide LCR-mediated
eﬀects.
In summary, our data show that HS2 deletion in 2B
e10.5 cells reduces the level of hug-gene transcription, even
though the b-globin locus maintains normal chromatin
organization. Moreover, other regions of the LCR
cannot compensate for loss of HS2 enhancer activity,
which is required in both e10.5 yolk sac and e12.5 fetal
liver EryC for high-level expression of the hue- (at e10.5)
and hug-genes (at e10.5 and e12.5), but not of the hub-
gene. Thus, LCR enhancer activity cannot prevent abnor-
mal globin gene expression due to alteration of chromatin
organization. Based on the mechanistic evidence provided
here, we propose that deletion of HS2 modiﬁes LCR
integrity and precludes eﬃcient long-range interactions
between LCR and hug-promoters, which in turn impairs
optimal PIC formation, promoter organization and,
hence, appropriate hug-gene expression levels.
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